AAAAAA
Results: 1-25/27
Authors:
WEAVER A
CHANG J
WRIGLEY E
DEWYNTER E
WOLL PJ
LIND M
JENKINS B
GILL C
WILKINSON PM
PETTENGELL R
RADFORD JA
COLLINS CD
DEXTER TM
TESTA NG
CROWTHER D
Citation: A. Weaver et al., RANDOMIZED COMPARISON OF PROGENITOR-CELL MOBILIZATION USING CHEMOTHERAPY, STEM-CELL FACTOR, AND FILGRASTIM OR CHEMOTHERAPY PLUS FILGRASTIM ALONE IN PATIENTS WITH OVARIAN-CANCER, Journal of clinical oncology, 16(8), 1998, pp. 2601-2612
Authors:
COIFFIER B
KETTERER N
HAIOUN C
ENGERT A
TILLY H
MA D
JOHNSON P
LISTER A
FEURINGBUSKE M
RADFORD JA
REYES F
DIEHL V
Citation: B. Coiffier et al., A MULTICENTER, RANDOMIZED PHASE-II STUDY OF RITUXIMAB (MABTHERA) AT 2DOSAGES IN PATIENTS WITH RELAPSED OR REFRACTORY INTERMEDIATE GRADE LYMPHOMA OR IN ELDERLY PATIENTS IN FIRST-LINE THERAPY, British Journal of Haematology, 102(1), 1998, pp. 238-238
Authors:
DOBSON LS
DUGGANKEEN M
RADFORD JA
STERN PL
MORGENSTERN GR
SCARFFE JH
CROWTHER D
Citation: Ls. Dobson et al., CAN INTERLEUKIN-2 IMMEDIATELY AFTER HIGH-DOSE CHEMOTHERAPY WITH PERIPHERAL STEM-CELL TRANSPLANTATION IN PATIENTS WITH LYMPHOMA BE A SAFE AND EFFECTIVE WAY OF CAUSING A GRAFT-VERSUS-LYMPHOMA EFFECT, British Journal of Cancer, 78, 1998, pp. 51-51
Authors:
DOBSON LS
DUGGANKEEN M
RADFORD JA
STERN PL
MORGENSTERN GR
SCARFFE HJ
CROWTHER D
Citation: Ls. Dobson et al., CYCLOSPORINE-A - CAN IT BE EFFECTIVELY GIVEN FROM THE DAY OF STEM-CELL RETURN IN PATIENTS WITH POOR-PROGNOSIS NON-HODGKINS-LYMPHOMA UNDERGOING HIGH-DOSE CHEMOTHERAPY WITH PERIPHERAL STEM-CELL TRANSPLANTATION, British Journal of Cancer, 78, 1998, pp. 52-52
Authors:
ADAMS M
CALVERT AH
CARMICHAEL J
CLARK PI
COLEMAN RE
EARL HM
GALLAGHER CJ
GANESAN TS
GORE ME
GRAHAM JD
HARPER PG
JAYSON GC
KAYE SB
LEDERMANN JA
OSBORNE RJ
PERREN TJ
POOLE CJ
RADFORD JA
RUSTIN GJS
SLEVIN ML
SMYTH JF
THOMAS H
WILKINSON PM
Citation: M. Adams et al., CHEMOTHERAPY FOR OVARIAN-CANCER - A CONSENSUS STATEMENT ON STANDARD PRACTICE, British Journal of Cancer, 78(11), 1998, pp. 1404-1406
Authors:
LEE SM
RADFORD JA
DOBSON L
HUQ T
RYDER WDJ
PETTENGELL R
MORGENSTERN GR
SCARFFE JH
CROWTHER D
Citation: Sm. Lee et al., RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR (FILGRASTIM) FOLLOWING HIGH-DOSE CHEMOTHERAPY AND PERIPHERAL-BLOOD PROGENITOR-CELL RESCUE IN HIGH-GRADE NON-HODGKINS-LYMPHOMA - CLINICAL BENEFITS AT NO EXTRA COST, British Journal of Cancer, 77(8), 1998, pp. 1294-1299
Authors:
COIFFIER B
HAIOUN C
KETTERER N
ENGERT A
TILLY H
MA D
JOHNSON P
LISTER A
FEURINGBUSKE M
RADFORD JA
CAPDEVILLE R
DIEHL V
REYES F
Citation: B. Coiffier et al., RITUXIMAB (ANTI-CD20 MONOCLONAL-ANTIBODY) FOR THE TREATMENT OF PATIENTS WITH RELAPSING OR REFRACTORY AGGRESSIVE LYMPHOMA - A MULTICENTER PHASE-II STUDY, Blood, 92(6), 1998, pp. 1927-1932
Authors:
RADFORD JA
EARDLEY A
WOODMAN C
CROWTHER D
Citation: Ja. Radford et al., FOLLOW-UP POLICY AFTER TREATMENT FOR HODGKINS-DISEASE - TOO MANY CLINIC VISITS AND ROUTINE TESTS - A REVIEW OF HOSPITAL RECORDS, BMJ. British medical journal, 314(7077), 1997, pp. 343-346
Authors:
GOSDEN RG
OKTAY K
RADFORD JA
RUTHERFORD AJ
Citation: Rg. Gosden et al., OVARIAN TISSUE-BANKING, Human reproduction, 12, 1997, pp. 19-19
Authors:
DOBSON M
CARRINGTON BM
RADFORD JA
BUCKLEY CH
CROWTHER D
Citation: M. Dobson et al., THE ROLE OF COMPUTED-TOMOGRAPHY IN THE MANAGEMENT OF OVARIAN-TUMORS OF BORDERLINE MALIGNANCY, Clinical Radiology, 52(4), 1997, pp. 280-283
Authors:
LEE SM
RADFORD JA
RYDER WDJ
COLLINS CD
DEAKIN DP
CROWTHER D
Citation: Sm. Lee et al., PROGNOSTIC FACTORS FOR DISEASE PROGRESSION IN ADVANCED HODGKINS-DISEASE - AN ANALYSIS OF PATIENTS AGED UNDER 60 YEARS SHOWING PRO PROGRESSION IN THE FIRST 6 MONTHS AFTER STARTING PRIMARY CHEMOTHERAPY, British Journal of Cancer, 75(1), 1997, pp. 110-115
Authors:
RADFORD JA
LIEBERMAN BA
CRITCHLOW JD
GOSDEN RG
CROWTHER D
SHALET SM
Citation: Ja. Radford et al., CRYOPRESERVATION OF OVARIAN CORTICAL STRIPS BEFORE HIGH-DOSE CHEMOTHERAPY (HDC) IN WOMEN DESIROUS OF FUTURE FERTILITY, Blood, 90(10), 1997, pp. 3940-3940
Authors:
RADFORD JA
CLARKE N
BROOK P
OCONNOR D
GOSDEN RG
CROWTHER D
SHALET SM
Citation: Ja. Radford et al., CRYOPRESERVATION OF SPERMATOGONIAL STEM-CELLS BEFORE CHEMOTHERAPY IN MEN DESIROUS OF FUTURE FERTILITY, Blood, 90(10), 1997, pp. 3941-3941
Authors:
BETTICHER DC
ZUCCA E
VONROHR A
EGGER T
RADFORD JA
AMBROSETTI A
BURKI K
RUFENER B
SCHMITZ SFH
CERNY T
Citation: Dc. Betticher et al., 2-CHLORODEOXYADENOSINE (2-CDA) THERAPY IN PREVIOUSLY UNTREATED PATIENTS WITH FOLLICULAR STAGE III-IV NON-HODGKINS-LYMPHOMA, Annals of oncology, 7(8), 1996, pp. 793-799
Authors:
WRIGLEY E
WEAVER A
JAYSON G
RANSON M
RENNINSON J
PRENDIVILLE J
DOBSON M
COLLINS CD
SWINDELL R
BUCKLEY CH
RADFORD JA
CROWTHER D
Citation: E. Wrigley et al., A RANDOMIZED TRIAL INVESTIGATING THE DOSE INTENSITY OF PRIMARY CHEMOTHERAPY IN PATIENTS WITH OVARIAN-CARCINOMA - A COMPARISON OF CHEMOTHERAPY GIVEN EVERY 4 WEEKS WITH THE SAME CHEMOTHERAPY GIVEN AT 3 WEEK INTERVALS, Annals of oncology, 7(7), 1996, pp. 705-711
Authors:
PETTENGELL R
RADFORD JA
MORGENSTERN GR
SCARFFE JH
HARRIS M
WOLL PJ
DEAKIN DP
RYDER D
WILKINSON PM
CROWTHER D
Citation: R. Pettengell et al., SURVIVAL BENEFIT FRONT HIGH-DOSE THERAPY WITH AUTOLOGOUS BLOOD PROGENITOR-CELL TRANSPLANTATION IN POOR-PROGNOSIS NON-HODGKINS-LYMPHOMA, Journal of clinical oncology, 14(2), 1996, pp. 586-592
Authors:
RADFORD JA
CROWTHER D
ROHATINER AZS
RYDER WDJ
GUPTA RK
OZA A
DEAKIN DP
ARNOTT S
WILKINSON PM
JAMES RD
JOHNSON RJ
LISTER TA
Citation: Ja. Radford et al., RESULTS OF A RANDOMIZED TRIAL COMPARING MVPP CHEMOTHERAPY WITH A HYBRID REGIMEN, CHLVPP EVA, IN THE INITIAL TREATMENT OF HODGKINS-DISEASE/, Journal of clinical oncology, 13(9), 1995, pp. 2379-2385
Authors:
CLARK ST
RADFORD JA
CROWTHER D
SWINDELL R
SHALET SM
Citation: St. Clark et al., GONADAL-FUNCTION FOLLOWING CHEMOTHERAPY FOR HODGKINS-DISEASE - A COMPARATIVE-STUDY OF MVPP AND A 7-DRUG HYBRID REGIMEN, Journal of clinical oncology, 13(1), 1995, pp. 134-139
Authors:
SCHEID C
PETTENGELL R
GHIELMINI M
RADFORD JA
MORGENSTERN GR
STERN PL
CROWTHER D
Citation: C. Scheid et al., TIME-COURSE OF THE RECOVERY OF CELLULAR IMMUNE FUNCTION AFTER HIGH-DOSE CHEMOTHERAPY AND PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION FOR HIGH-GRADE NON-HODGKINS-LYMPHOMA, Bone marrow transplantation, 15(6), 1995, pp. 901-906
Authors:
WONGYOUCHEONG J
RADFORD JA
Citation: J. Wongyoucheong et Ja. Radford, CASE-REPORT - ENLARGEMENT OF A MEDIASTINAL MASS DURING TREATMENT FOR HODGKINS-DISEASE MAY BE DUE TO ACCUMULATION OF FLUID WITHIN THYMIC CYSTS, Clinical Radiology, 50(1), 1995, pp. 61-62
Authors:
RADFORD JA
WHELAN JS
ROHATINER AZS
DEAKIN D
HARRIS M
STANSFELD AG
SWINDELL R
WILKINSON PM
JAMES RD
LISTER TA
CROWTHER D
Citation: Ja. Radford et al., WEEKLY VAPEC-B CHEMOTHERAPY FOR HIGH-GRADE NON-HODGKINS-LYMPHOMA - RESULTS OF TREATMENT IN 184 PATIENTS, Annals of oncology, 5(2), 1994, pp. 147-151
Authors:
SCHEID C
PETTENGELL R
GHIELMINI M
RADFORD JA
MORGENSTERN GR
CROWTHER D
STERN PL
Citation: C. Scheid et al., RAPID IMMUNOLOGICAL RECONSTITUTION AFTER HIGH-DOSE CHEMOTHERAPY AND PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN HIGH-GRADE NON-HODGKIN-LYMPHOMA, Experimental hematology, 22(8), 1994, pp. 781-781
Authors:
RADFORD JA
CLARK S
CROWTHER D
SHALET SM
Citation: Ja. Radford et al., MALE-FERTILITY AFTER VAPEC-B CHEMOTHERAPY FOR HODGKINS-DISEASE AND NON-HODGKINS-LYMPHOMA, British Journal of Cancer, 69(2), 1994, pp. 379-381
Authors:
RADFORD JA
MORGENSTERN GR
CROWTHER D
Citation: Ja. Radford et al., THE MANAGEMENT OF HODGKINS-DISEASE, Annals of oncology, 4(5), 1993, pp. 417-421
Authors:
VANHOEF MEHM
RADFORD JA
JONES A
SMITH IE
EARL HM
WOLL PJ
THATCHER N
Citation: Mehm. Vanhoef et al., URINARY-DERIVED MONOCYTE-COLONY STIMULATING FACTOR (P-100) FOLLOWING TREATMENT WITH CARBOPLATIN AND ETOPOSIDE IN SMALL-CELL LUNG-CANCER (SCLC), Annals of oncology, 4(10), 1993, pp. 877-881